MedTrace Logo

Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging

NCT04345094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-07-10

No results posted yet for this study

Summary

Photoaging is a common concern within the cosmeceutical industry with many products that are available. One frequently used product is hydroquinone that is used to even skin tone. However, hydroquinone has several shortcomings. The ingredient is controversial for its potential safety issues and it has been banned in Europe. An alternative ingredient that has emerged for its potential use is hexyresorcinol for evening skin tone. Additionally, hexylresorcinol may have other photoaging benefits such as the reduction in the appearance of fine lines.

Therefore, the aim of this study is to assess how hexyresorcinol may compare to the use of hydroquinone in the setting of photoaging.

Conditions

  • Photoaging

Interventions

OTHER

Hexylresourcinol

Emulsion containing hexylresorcinol as an active

OTHER

Hydroquinone

Emulsions containing hydroquinone as an active

Sponsors & Collaborators

  • Sytheon Ltd.

    lead INDUSTRY

Principal Investigators

  • Raja Sivamani, MD · Pacific Skin Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-12-24
Completion
2020-02-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04345094 on ClinicalTrials.gov